Medtech firms may face additional costs in wake of ACA ruling
05:55 EDT 2 Jul 2012 | SmartBrief
A Kalorama Information report says the medtech industry could face additional financial burdens as a result of the Supreme Co -More-
Original Article: Medtech firms may face additional costs in wake of ACA ruling
More From BioPortfolio on "Medtech firms may face additional costs in wake of ACA ruling"
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
